UBM Medica provides reference data, decision support solutions, news and education to communities of general practitioners, specialist doctors, pharmacists, nurses and patients. We serve the needs of these communities in 26 countries.

We produce a range of professional media including data-rich directories, electronic and online products, journals and face-to-face meetings.  The established and trusted reputation of our brands means that many of them are embedded in the daily workflow of the healthcare communities they serve.

 

Drug Information Systems (DIS)
UBM Medica’s DIS businesses produce a range of essential reference and decision support tools, used at the point of care by doctors, pharmacists, hospitals and consumers to access drug and disease information.

We operate in 23 countries, and have the pre-eminent national drug information brands in France (Vidal), Spain (Vademecum), Portugal (Simposium), China (MIMS), Hungary and Poland (PHARMINDEX), India (CIMS and IDR), Russia (Vidal), Australia (MIMS) and New Zealand (MIMS) with a strong position in Germany (Gelbe Liste).  Each DIS brand has at its core a rich, deep and often unique data set from which a variety of print and electronic product offerings are generated.

We produce a range of DIS products supported by the pharma industry including:


We produce a range of premium DIS products bought by individual end-users and institutions:


Find out more about our DIS businesses

 

Journals
At the heart of UBM Medica’s business is a series of highly respected, market leading brands focused on particular communities within the healthcare profession.  These brands provide their communities with a trusted source for clinical and practice management news and information.  The brands provide advertisers with access to high value, qualified audiences.

The origin of most of UBM Medica’s brands is a print journal but many have expanded to provide a range of services including supplements, seminars and events, online resources and custom publishing.

UBM Medica produces a unique portfolio of leading journal brands covering a range of audiences from primary care physicians, secondary care specialists, pharmacists, and healthcare system managers, and as well as some consumer focused titles.

Well known and respected UBM Medica journals include: Le Quotidien du Médecin, Le Généraliste and Le Quotidien du Pharmacien in France, Psychiatric Times, Oncology, Diagnostic Imaging, Consultant and Physicians’ Practice in the US, Kassenarzt in Germany, Medical Tribune across Asia and The Medical Observer in Australia.

Find out more about our Journal businesses

 

Online
UBM Medica’s portfolio of online services is expanding as the healthcare communities we serve spend more time using the web as a professional resource.  We have created a range of interactive services that provide reference data, information and education resources.

UBM Medica’s online services fall into four main areas:


Where these services are industry-supported they provide a cost effective and measurable channel.

Find out more about opportunities within our online businesses

 

CME
As medical science continues to develop new treatments and payors place a greater focus on clinical outcomes there is a growing need for continuing medical education (CME) and professional development.  UBM Medica’s CME business provides industry-supported, accredited education to select communities of physicians.  Education is delivered through a balanced portfolio of media.

The majority of UBM Medica’s CME activity is in the US where we provide accredited education to medical professionals such as psychiatrists, oncologists and primary care physicians.  The educational programmes offered cover the latest medical advances, treatment options and preventive healthcare methods through a variety of learning formats.  It now caters for large audiences by providing and organizing its own branded events, meetings/discussion groups as well as online, podcast products and e-newsletters.

Our CME business operates separately from the professional media businesses in order to comply with relevant regulations. UBM Medica grants professional credits to physicians for completing CME courses or attending its meetings. All educational programmes are ACCME-accredited and utilize a quality assurance process in compliance with ACCME, OIG and FDA guidelines.  Most of these programmes are supported in part or whole by unrestricted educational grants from pharmaceutical companies.

Our key CME services include: The US Psychiatric and Mental Health Congress, (the second largest psychiatric educational conference in the US), Advances in Primary Care Medicine, Advances in Neurology, Advances in Pediatrics (multi-city one-day event series), Virtual Symposia (online webcasts of key educational sessions sessions from our meetings), and the Oncology e-newsletter updates.

Find out more about our CME businesses

 

Events
Interacting with your healthcare customers in a face to face environment is one of the most effective and enjoyable ways of selling your products and learning more about your customers needs.

UBM Medica owns and runs a series of large healthcare events.

Key events include:


Find out more about our Event businesses

 

Marketing Services
Working with you to develop your communications to the many healthcare audiences reached through the diverse range of journals, online businesses, events and drug information systems is an integral part of the UBM Medica service.

UBM Medica offers a complete marketing service to ensure you maximise the impact of your marketing and product messages across our global healthcare audiences in the most cost effective way to match your goals, budget and timescales.

Find out more about how we can work with you on your marketing programmes.

About Us